You are interested in the opportunity Development of novel class of compounds for eye delivery to stop neurodegeneration in glaucoma.
If you already have an account with the Enterprise Europe Network, select I already have an
account. From here, you can login and get in touch about this opportunity.
If you do not yet have an account, select Create an account. We will send an activation link to
your email address. If you do not receive this email, please check your spam folder.
As soon as you activate your account, you will be directed back to this page to create your
expression of interest.